Bvf Inc Kymera Therapeutics, Inc. Transaction History
Bvf Inc
- $2.54 Billion
- Q2 2025
A detailed history of Bvf Inc transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 5,502,710 shares of KYMR stock, worth $260 Million. This represents 9.44% of its overall portfolio holdings.
Number of Shares
5,502,710
Previous 5,161,801
6.6%
Holding current value
$260 Million
Previous $141 Million
69.98%
% of portfolio
9.44%
Previous 6.21%
Shares
8 transactions
Others Institutions Holding KYMR
# of Institutions
217Shares Held
72.2MCall Options Held
178KPut Options Held
64.6K-
Price T Rowe Associates Inc Baltimore, MD6.86MShares$324 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.65MShares$314 Million2.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.56MShares$310 Million5.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$266 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA5.37MShares$254 Million0.04% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.59B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...